Bank Hapoalim BM’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,925
Closed -$504K 255
2021
Q4
$504K Sell
10,925
-1,247
-10% -$57.5K 0.05% 167
2021
Q3
$577K Sell
12,172
-290
-2% -$13.7K 0.06% 155
2021
Q2
$645K Sell
12,462
-1,080
-8% -$55.9K 0.07% 155
2021
Q1
$682K Sell
13,542
-830
-6% -$41.8K 0.09% 143
2020
Q4
$748K Sell
14,372
-520
-3% -$27.1K 0.1% 119
2020
Q3
$647 Sell
14,892
-15,880
-52% -$690 0.03% 104
2020
Q2
$1.32M Buy
30,772
+2,710
+10% +$117K 0.31% 64
2020
Q1
$1.01M Sell
28,062
-2,423
-8% -$87.4K 0.32% 65
2019
Q4
$1.39M Buy
30,485
+2,315
+8% +$106K 0.31% 63
2019
Q3
$1.01M Buy
28,170
+880
+3% +$31.5K 0.25% 64
2019
Q2
$1.09M Sell
27,290
-845
-3% -$33.7K 0.27% 68
2019
Q1
$1.17M Buy
28,135
+11,070
+65% +$460K 0.28% 62
2018
Q4
$625K Buy
17,065
+3,650
+27% +$134K 0.2% 80
2018
Q3
$651K Buy
13,415
+550
+4% +$26.7K 0.16% 102
2018
Q2
$553K Buy
12,865
+694
+6% +$29.8K 0.15% 120
2018
Q1
$510K Buy
12,171
+90
+0.7% +$3.77K 0.13% 115
2017
Q4
$526 Sell
12,081
-1,060
-8% -$46 0.12% 125
2017
Q3
$559K Buy
13,141
+2,760
+27% +$117K 0.13% 132
2017
Q2
$447K Sell
10,381
-2,195
-17% -$94.5K 0.11% 136
2017
Q1
$526K Sell
12,576
-1,755
-12% -$73.4K 0.12% 117
2016
Q4
$560K Buy
14,331
+7,575
+112% +$296K 0.15% 103
2016
Q3
$299K Sell
6,756
-580
-8% -$25.7K 0.07% 154
2016
Q2
$307K Sell
7,336
-132
-2% -$5.52K 0.07% 142
2016
Q1
$301K Sell
7,468
-11,962
-62% -$482K 0.07% 131
2015
Q4
$995K Sell
19,430
-19,754
-50% -$1.01M 0.23% 70
2015
Q3
$1.84M Buy
39,184
+2,544
+7% +$119K 0.43% 51
2015
Q2
$2.29M Buy
36,640
+10,110
+38% +$630K 0.45% 44
2015
Q1
$1.64M Buy
+26,530
New +$1.64M 0.3% 60